TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2024. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,938 | -6.8% | 227 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $3,154 | -2.7% | 227 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $3,240 | -7.7% | 227 | 0.0% | 0.00% | -33.3% |
| Q3 2023 | $3,512 | -1.5% | 227 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $3,567 | -4.7% | 227 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $3,741 | +5.6% | 227 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,542 | +20.3% | 227 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $2,945 | -7.6% | 227 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,188 | -1.9% | 227 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,251 | +5.0% | 227 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $3,095 | – | 227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
| Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
| NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
| Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
| Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
| Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
| Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
| Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
| Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
| Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |